Low level expression of an active Raf kinase results in a transformed phenotype; however, high intensity Raf signals block cell cycle progression. Phospholipase D (PLD) has been implicated in regulating cell cycle progression and PLD activity is elevated in Raf transformed cells. We report here that high intensity Raf signals reduce PLD activity and that elevated expression of either PLD1 or PLD2 prevents cell cycle arrest induced by high intensity Raf signals. Overexpression of either PLD1 or PLD2 also reversed increases in p21
Low level expression of an active Raf kinase results in a transformed phenotype; however, high intensity Raf signals block cell cycle progression. Phospholipase D (PLD) has been implicated in regulating cell cycle progression and PLD activity is elevated in Raf transformed cells. We report here that high intensity Raf signals reduce PLD activity and that elevated expression of either PLD1 or PLD2 prevents cell cycle arrest induced by high intensity Raf signals. Overexpression of either PLD1 or PLD2 also reversed increases in p21
Cip1 and protein kinase C d (PKC d) cleavage seen with high intensity Raf signals. These data indicate that PLD signaling provides a novel survival signal that overcomes cell cycle arrest induced by high intensity Raf signaling. Oncogene (2002) 21, 3651 ± 3658. DOI: 10.1038/sj/ onc/1205380 Keywords: phospholipase D; Raf; cell cycle; survival signals An important aspect of mitogenic signal transduction is that incomplete or inappropriate proliferation signals can lead to cell cycle arrest, cell senescence, and even apoptosis (Evan and Littlewood, 1998 ). An emerging paradigm is that there are mechanisms in place to insure that unwanted cell proliferation does not happen (Hueber and Evan, 1998; Hanahan and Weinberg, 2000) . Weinberg and colleagues demonstrated several years ago that primary cells require two cooperating oncogenes to generate a transformed cell in culture (Land et al., 1983) . In general, oncogenes that mediate the transduction of mitogenic signals require a second genetic alteration that overcomes restrictions upon cell cycle progression. For example, the signal transducing Ras oncogene cooperates with SV40 large T-antigen, which interferes with inhibition of cell cycle progression through cell cycle checkpoints (Sherr, 1996) .
Expression of an activated Ras oncogene in the absence of a cooperating oncogene results in cell senescence or apoptosis (Serrano et al., 1997; Joneson and Bar-Sagi, 1999) depending upon the strength of the signal. Similarly Myc, which like SV40 large T-antigen, cooperates with Ras to transform primary cell (Land et al., 1983) , stimulates apoptosis under growth restrictive conditions (Askew et al., 1991; Evan et al., 1992) . Thus, there is a delicate balance between cell division, cell cycle arrest, and cell death that is carefully regulated.
The serine-threonine kinase Raf is a downstream target of Ras signaling that, when activated by mutation, functions as an oncogene (Rapp et al., 1987) . As noted for activated Ras (Franza et al., 1986; Hirakawa and Ruley, 1988) , too much Raf signaling leads to cell cycle arrest rather than proliferation (Samuels and McMahon, 1994; Kerkho and Rapp, 1998; Woods et al., 1997; Zhu et al., 1998; Sewing et al., 1997) . These observations suggest that high intensity Raf signals are recognized as inappropriate, leading to a block in cell cycle progression.
We reported previously that phospholipase D (PLD) activity is elevated in NIH3T3 cells transformed by vRaf . PLD has been implicated in cell transformation by v-Src, v-Ras (Aguirre Ghiso et al., 1999) , and v-Raf (Urano et al., 1996) . In addition, PLD was able to cooperate with overexpressed epidermal growth factor receptor to transform rat ®broblasts (Lu et al., 2000) , in much the same way that T-antigen cooperates with Ras. Thus, PLD likely provides a survival signal that, like T-antigen, facilitates the override of cell cycle checkpoints. In this study, we have investigated the eect of PLD on high intensity Raf signals, which causes cell cycle arrest.
High intensity Raf signal reduces PLD activity
Several studies have shown that a high intensity Raf signal leads to cell cycle arrest and cell senescence (Woods et al., 1997; Sewing et al., 1997; Zhu et al., 1998; Kerkho and Rapp, 1998) . NIH3T3 cells expressing estrogen receptor ± Raf fusion proteins inducible by OHT (BxB-Raf-ER 2 cells) were generated as described previously (Kerkho and Rapp, 1997 Rapp, , 1998 Rapp, 1998) . Thus, addition of OHT to cells with high expression gave a high intensity Raf signal resulting in increased levels of the cyclin-dependent kinase inhibitor p21 Cip1 and cell cycle arrest (Kerkho and Rapp, 1998) . We reported previously that PLD activity is elevated in Raf-transformed cells . Consistent with this observation, induction of Raf kinase activity with OHT in the low expressing Raf-ER cells results in increased PLD activity (Figure 1a) . However, in the high level expressing Raf-ER cells, PLD activity was suppressed by OHT (Figure 1b) . The high level Raf-ER expressing cells expressed a higher basal level of PLD activity relative to the parental NIH3T3 cells (not shown), presumably due to a higher basal kinase activity of the overexpressed Raf-Raf-ER protein as described previously (Kerkho and Rapp, 1998) . The time course for reduced PLD activity was consistent with the time course for induction of Raf kinase activity described previously (Kerkho and Rapp, 1998) . The dose response for the decreased PLD activity ( Figure 1c ) correlated with that observed for the increase in Raf kinase activity as determined by increased phosphorylation of MEK (mitogen-activated protein kinase-kinase) (Figure 1d ). These data indicate that, in contrast to the increase in PLD activity observed in response to a low intensity Raf signal, a high intensity Raf signal reduces PLD activity.
PLD expression in Raf-ER cells
The suppression of PLD activity by high intensity Raf signaling implicates PLD in the cell cycle arrest induced by the high level of Raf kinase. To address this question, we wished to elevate PLD activity in the high level expressing Raf-ER cells. Overexpression of PLD is frequently toxic (Lu et al., 2000) . Therefore, an ecdysone inducible expression system was developed for both PLD1 (Hammond et al., 1995) and PLD2 . PLD expression could then be regulated by addition of ponasterone A (PonA). The high level expressing Raf-ER cells, stably-transfected with PLD1 (Raf-ER-P1) and PLD2 (Raf-ER-P2) constructs, were examined for PLD expression by Western analysis. Upon induction with PonA, increased PLD protein ( Figure  2a ) and activity ( Figure 2b ) could be detected in the Raf-ER-P1 and Raf-ER-P2 cells between 4 and 12 h. The induction of PLD protein and activity were observed in both the absence and presence of OHT (high intensity Raf signals) (Figure 2a,b) . The induction of PLD2 was more pronounced than the induction of PLD1, consistent with previous observations indicating that PLD1 expression is more toxic to cells than PLD2 expression (our unpublished results). The induction of either PLD1 or PLD2 had no obvious eect upon either Raf protein levels (Figure 2c ) or MEK phosphorylation levels ( Figure 2d ).
PLD activity suppresses p21
Cip1 levels and protein kinase
induced by high intensity Raf signals
Several reports have shown that the cyclin dependent kinase inhibitor p21
Cip1 is elevated in response to high intensity Raf signals (Woods et al., 1997; Zhu et al., 1998; Kerkho and Rapp, 1998) . We therefore investigated the eect of PLD upon p21
Cip1 levels. As shown in Figure 3a , the Raf-ER-P1 and Raf-ER-P2 cells still responded to OHT with an increase in p21 Cip1 levels. This was important because, as noted above, there was some leakiness in the expression of PLD1 and PLD2 in the absence of the inducer PonA. If OHT-treated Raf-ER-P1 and Raf-ER-P2 cells were treated with PonA, p21
Cip1 levels were substantially reduced in the cells expressing either PLD1 or PLD2 (Figure 3b ). The time course for reduced p21
Cip1 levels was consistent with time course for elevated PLD activity seen in Figure 2b . These data demonstrate that elevating either PLD1 or PLD2 activity reverses the increase in p21
Cip1 levels induced by high intensity Raf signaling.
In response to apoptotic stimuli, PKC d is proteolytically cleaved by caspase 3 (Emoto et al., 1995; Ghayur et al., 1996; Pongracz et al., 1999) to generate a characteristic 40 kDa PKC d fragment sometimes referred to as PKM (protein kinase M) (Cressman et al., 1995) . The generation of PKM has been used as a marker for caspase 3 activity and apoptosis (Zhong et al., 2002; Pongracz et al., 1999; Villalba, 1998) . As shown in Figure 3c , activation of Raf with OHT in the Raf-ER-P1 and Raf-ER-P2 cells subjected to serum withdrawal resulted in and increase in the level of PKC d by 40 h and the appearance of a 45 kDa PKC d fragment. In contrast, if the cells were pretreated with Pon A to elevate either PLD1 or PLD2 expression, there was a reduction of PKC d levels and no detectable production of the 40 kDa PKC d fragment. Thus, elevated expression of either PLD1 or PLD2 expression, there was a reduction of PKC d levels and no detectable production of the 40 kDa PKC d fragment. Thus, elevated expression of either PLD1 or PLD2 reverses the eects of high intensity Raf signaling on PKC d expression and cleavage.
PLD restores proliferative capacity to cells subjected to high intensity Raf signals
We next examined the eects of elevated PLD expression on cell proliferation in OHT-treated Raf-ER cells. Raf-ER-P1 and Raf-ER-P2 cells in culture were allowed to reach con¯uence, at which time they were treated with either OHT or OHT and PonA. As shown in Figure 4a , both Raf-ER-P1 and Raf-ER-P2 cells continued to proliferate in the presence of PonA, but not in the absence of PonA. We also examined the eect of PLD upon the ability of the Raf-ER-P1 and Raf-ER-P2 cells to proliferate in low serum. As shown in Figure 4b , withdrawal of serum from the OHT-induced Raf-ER cells resulted in cell death and reduced cell number. However, in the presence of PonA, the cells not only survived, they continued to proliferate as well (Figure 4b ). These data are consistent with the results obtained in Figure 3c , where it was shown that serum withdrawal to Raf-ER cells led to PKC d cleavage and that elevated expression of PLD overcame this eect. These data indicate that PLD not only overrides the inhibition of cell cycle progression induced by high intensity Raf signals, but also provides a survival signal that prevents cell death.
We next examined whether PLD expression would facilitate anchorage independent growth in presence of a high intensity Raf signal. As shown in Figure  4c , both PLD1 and PLD2 stimulated colony formation in the Raf-ER cells in both the presence and absence of OHT. The ability to stimulate anchorage independent growth in the absence of OHT indicates that PLD expression cooperates with the leaky Raf signal in the Raf-ER cells to stimulate anchorage independent growth. More signi®cantly, however, PLD was able to overcome the cell cycle arrest induced by high intensity Raf signals to allow anchorage independent growth. Note also that in the presence of OHT there are no background colonies as seen in the absence of OHT. We also examined DNA synthesis in con¯uent Raf-ER-P1 and Raf-ER-P2 cells, and consistent with the increased cell number and colony formation observed with PonA treatment, PonA also stimulated an increase in DNA synthesis in both the Raf-ER-P1 and Raf-ER-P2 cells ( Figure 4d ). As observed for colony formation, PonA induced an increase in DNA synthesis in the absence of OHT (Figure 4d ), further indicating cooperation between PLD activity and the leaky Raf signal to stimulate cell cycle progression. The data in Figure 4 Oncogene Phospholipase D overcomes cell cycle arrest T Joseph et al Figure 1 at the indicated times after addition of PonA. Generation of Raf-ER cell lines that conditionally express PLD1 and PLD2: Inducible expression vectors for PLD1 and PLD2 were generated as follows. pBluescript-SK-mPLD1 and pBluescript-SK-hPLD2 (Hammond et al., 1995; Colley et al., 1997) were obtained from Dr Michael Frohman (SUNY-Stony Brook). The mPLD1 gene was excised with Sal1 and Xba1, the hPLD2 gene with Not1 and Sal1 restriction endonucleases respectively. These genes were ligated into the polylinker region of the PEGSH expression plasmid (Stratagene). The plasmids were ampli®ed in E. Coli (strain XL-1 Blue host strain b ) (Stratagene). The mPLD1-PEGSH and the hPLD2-PEGSH plasmids were then transfected separately into Raf-BxB-ER 2 cells. Clones were co-transfected with PERV3 (Stratagene) using G418 selection as described previously (Lu et al., 2000) . Clones were analysed for PLD expression as described in the text. Transfections were performed using Lipofectamine reagent (GIBCO) as described previously (Lu et al. (2000) ). Selection used either G418 (400 mg/ml) or hygromycin (200 mg/ml) for 10 ± 14 days at 378C, when antibiotic-resistant colonies were expanded for further analysis under selective conditions demonstrate that elevated expression of either PLD1 or PLD2 provides a survival signal that overcomes the inhibitory eects of high intensity Raf signals upon cell proliferation.
NIH3T3 cells transformed by activated Raf have an elevated PLD activity that is dependent upon both Rho and Ral . The transformation of NIH3T3 cells by activated Raf selects for cells that express modest or low levels of activated Raf kinase (Kerkho and Rapp, 1998) . Using an inducible Raf kinase selected under noninduced conditions, much higher levels of Raf expression were obtained; however, induction of Raf kinase with OHT in the high expression of Raf-ER cells resulted in cell cycle arrest rather than transformation (Kerkho and Rapp, 1998) . In this study, we showed that high intensity Raf signals do not lead to the increased PLD activity seen with the low expression Raf-ER cells and in Raf-transformed cells . In contrast, the high intensity Raf signal repressed PLD activity. Overexpression of either PLD1 or PLD2 in the background of the high intensity Raf signal overcame the Raf-induced cell cycle arrest. These data indicate that PLD activity provides signal that overcomes the cell cycle arrest signals generated by the high intensity Raf signal.
We previously reported that overexpression of PLD1 cooperated with overexpression of the EGF receptor to transform rat ®broblasts. Models for the cooperation 3 Raf-ER-P1 or Raf-ER-P2 cells were suspended in soft agar as described previously (Lu et al., 2000) . OHT (200 nM) and PonA (10 mM) were added as indicated. Fresh media including OHT and PonA were added every 4 days. Colonies were counted 14 days after suspension and the percentage of cells that formed colonies was determined. Error bars represent the standard error for triplicate samples from a representative experiment that was repeated two times. (d) Raf-ER-P1 and Raf-ER-P2 cells were allowed to reach con¯uence in 24-well plates and DNA synthesis was determined by measuring the incorporation of [ between oncogenic signals in the transformation of primary signals have been proposed (Land et al., 1983; Hirakawa and Ruley, 1988; Rapp et al., 1987; Troppmair et al., 1992) . According to the models, signaling oncogenes like Ras, Src and Raf cooperate with oncogenes like T-antigen and Myc, which facilitate passage through cell cycle checkpoints. The ability of PLD1 to cooperate with the EGF receptor (Lu et al., 2000) would suggest a role for PLD in facilitating passage through cell cycle checkpoints. The data presented here are consistent with such a model whereby PLD overcomes activation of cell cycle checkpoint controls by the high intensity Raf signals.
Many proteins that regulate cell cycle progression such as p53 also regulate apoptosis (Evan and Littlewood, 1998) , and in this regard, it is of interest that overexpression of PLD apparently prevented apoptosis in Raf-ER cells subjected to serum withdrawal (see Figure 4b ). Consistent with this, serum withdrawal to the Raf-ER cells also resulted in the cleavage of PKC d, which is mediated by caspase 3 (Ghayur et al., 1996; Emoto et al., 1995; Pongracz et al., 1999) , and this eect was also reversed by elevated expression of PLD. Thus, it is possible that in addition to preventing cell cycle arrest, PLD also generates a survival signal that prevents apoptosis. It is not clear how PLD contributes to mitogenic signaling. PLD catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid and choline (Exton, 1998) . We recently showed that PLD is required for receptor-mediated endocytosis (Shen et al., 2001) . Similarly, the PLD regulator RalA (Jiang et al., 1995; Luo et al., 1997 Luo et al., , 1998 has recently been implicated in receptor endocytosis (Nakashima et al., 1999; JullienFlores et al., 2000) . Thus, PLD may contribute to mitogenic signaling by facilitating receptor endocytosis, which has been implicated in the transduction of intracellular signals (Vieira et al., 1996; Kranenberg et al., 1999; Shen et al., 2001) . Another possible consequence of signaling through PLD is the membrane recruitment of Raf, which has a phosphatidic acid binding site in its C-terminus (Ghosh et al., 1996; Rizzo et al., 1999) . Thus, while a precise mechanism for the involvement of PLD in mitogenic signaling is not known, PLD signaling apparently provides a survival signal that, like T-antigen, is able to override cell cycle checkpoint controls. A role for PLD in regulating cell cycle progression, and possibly apoptosis, suggests that upregulating PLD might contribute to cancer progression. Consistent with this idea, elevated PLD activity was reported to be elevated in 14 of 17 human breast cancer tissues (Noh et al., 2000) . Agonists that elevate PLD activity might also contribute to cancer by generating signals that stimulate the proliferation of cells that have acquired a mutation that would ordinarily undergo apoptosis or cell cycle arrest. In this context, compounds with the ability to elevate PLD activity would have tumor-promoting eects in cells that have acquired an initiating mutation to a signaling oncogene such as Raf. In this regard, it is of interest that tamoxifen, which has been implicated as a tumor promoter in human endometrial cancer (Fisher et al., 1994) , stimulates PLD activity in cells overexpressing the tyrosine kinase c-Src (Zhong et al., 2001) .
